Alnylam Pharmaceuticals
ALNY
#650
Rank
$39.26 B
Marketcap
$294.06
Share price
2.04%
Change (1 day)
-9.52%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company